Clinical Trial Update: Novel Dose Adjustment Schedule for Late Injection in SCIT in AR [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a novel dose adjustment schedule for late injection in subcutaneous immunotherapy for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Allergic Rhinitis, Immunotherapy | Phase 4 | Status: COMPLETED